Synonym: 3′,4′-Didehydro-4′-deoxy-C′-norvincaleukoblastine [R-(R*,R*)-2-3-dihydroxybutanedioate (1:2)salt]; 5′-Noranhydrovinoblastine tartrate; KW-2307; NVB; Navelbine tartrate
CAS Number: 125317-39-7 (anhydrous)
Empirical Formula (Hill Notation): C45H54N4O8 · 2C4H6O6 · xH2O
Molecular Weight: 1079.11 (anhydrous basis)
MDL Number: MFCD03613607
Linear Formula: C45H54N4O8 · 2C4H6O6 · xH2O
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts V2264-5MG.
| assay |
≥98% (HPLC) |
| color |
off-white |
| form |
powder |
| InChI |
1S/C45H54N4O8.2C4H6O6.H2O/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7;2*5-1(3(7)8)2(6)4(9)10;/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3;2*1-2,5-6H,(H,7,8)(H,9,10);1H2/t28-,37-,38+,39+,42+,43+,44-,45-;2*1-,2-;/m011./s1 |
| InChI key |
ZLIPKSVXTCRHIB-GNBHHJMASA-N |
| originator |
Pierre Fabre |
| Quality Level |
100  |
| shipped in |
wet ice |
| SMILES string |
[H]O[H].O[C@H]([C@@H](O)C(O)=O)C(O)=O.O[C@H]([C@@H](O)C(O)=O)C(O)=O.[H][C@]12C[N@H](CC(CC)=C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@@]7([H])[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@]89[H])C(=O)OC |
| solubility |
H2O: 10 mg/mL |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Potent anti-mitotic, anti-tumor agent; inhibits microtubule assembly. |
| Biochem/physiol Actions: |
Vinorelbine is a potent anti-mitotic, anti-tumor agent. Vinorelbine inhibits microtubule assembly. Low neurotoxicity is related to its higher affinity for mitotic microtubules than for axonal microtubules. |
| Features and Benefits: |
This compound was developed by Pierre Fabre . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
5 mg in glass bottle |
| Symbol |
GHS07 |
| Signal word |
Warning |
| Hazard statements |
H317 |
| Precautionary statements |
P280 |
| Hazard Codes |
Xi |
| Risk Statements |
43 |
| Safety Statements |
26-36 |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |